SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,541,444 | +122.8% | 260,200 | +110.5% | 5.74% | +107.3% |
Q2 2023 | $14,154,672 | +49.6% | 123,600 | +69.3% | 2.77% | +49.5% |
Q4 2022 | $9,459,340 | -34.9% | 73,000 | -62.4% | 1.85% | -46.8% |
Q2 2022 | $14,535,000 | +11.0% | 193,900 | +33.4% | 3.49% | +19.8% |
Q4 2021 | $13,094,000 | +15.5% | 145,405 | -41.8% | 2.91% | +31.9% |
Q3 2017 | $11,340,000 | +148.9% | 250,000 | +4.6% | 2.21% | +69.0% |
Q2 2016 | $4,556,000 | +55.6% | 238,900 | +59.3% | 1.30% | +24.2% |
Q1 2016 | $2,928,000 | – | 150,000 | – | 1.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |